BCL2 and B-cell chronic lymphocytic leukemia: Interestingly, neither mutation of BCL2 was detected in any of the samples from the 8 patients studied by Herling et al. [89], providing further evidence that these mutations do not account for every case of venetoclax-resistant CLL.